Načítá se...
Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers
Immune checkpoint blockers improve the overall survival of a limited number of patients among different cancers. Identifying pathways that influence the immunological and clinical response to treatment is critical to improve the therapeutic efficacy and predict clinical responses. Recently, a key ro...
Uloženo v:
| Vydáno v: | Clin Exp Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160664/ https://ncbi.nlm.nih.gov/pubmed/32297328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13433 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|